If you thought your week was bad, imagine being Medline. On Thursday, a fire ripped through the company's massive distribution center in Tracy, California, sending a plume of thick black smoke into the sky and forcing evacuations at nearby industrial facilities. The blaze, which broke out at Medline's 1 million-square-foot warehouse, also spread to a neighboring FedEx Corp. (FDX) facility before firefighters stopped it from doing more damage. Local authorities confirmed that all Medline employees and personnel were accounted for — a small mercy in an otherwise chaotic scene.
The fire fully engulfed the Medline building, according to Tracy Mayor Dan Arriola, but stayed away from residential areas. Fire Chief Randall Bradley noted that firefighting efforts were hampered by a malfunctioning sprinkler system and low water pressure at the warehouse. The cause is under investigation, and air quality monitoring is ongoing. The industrial park also houses distribution centers for Amazon.com, Inc. (AMZN) and Home Depot, Inc. (HD), but those were evacuated as a precaution due to strong winds carrying embers.
So, what does this mean for Medline's business? William Blair analyst Brandon Vazquez ran the numbers. The destroyed facility accounts for roughly 4% of Medline's total U.S. warehouse space and about 3% globally. That's not insignificant, but it's also not catastrophic. Vazquez's take: Medline is a company that prioritizes its customers, so it will spend whatever it takes to keep orders flowing. That means margins could take a hit in the short term as the company scrambles to reroute inventory and cover fulfillment costs. "Our take is that a company that prioritizes customers like Medline will spend to make sure customer orders are fulfilled, so margins could see some impact in the short term," Vazquez said.
On top of the fire, Medline is dealing with an FDA warning letter issued last week. The letter followed an October 2025 inspection of its drug manufacturing facility in Waukegan, Illinois, where regulators found significant violations related to recurring microbial contamination, inadequate investigations, and weak manufacturing controls. The FDA's main concern was repeated contamination of certain drug products with objectionable microorganisms. That's a separate headache, but it adds to the near-term headwinds Vazquez mentioned.
Despite all this, Vazquez expects the stock impact to be limited over the medium term. Medline's scale should allow it to meet customer demand and fulfill orders, even with one major facility offline. The damaged inventory will need to be replenished, which creates a near-term headwind alongside inflationary pressures, but the company's size gives it flexibility. As of Friday's publication, Medline shares were down 2.53% at $36.19 — a modest dip that suggests investors are taking a wait-and-see approach.
In short, the fire is a real problem, but not an existential one. Medline has the resources to adapt, and the market seems to agree. The bigger question might be how the FDA situation plays out, but for now, the focus is on getting that California warehouse back online — or finding a workaround.
